OTCMKTS:TRSSF

TerrAscend Price Target, Predictions & Analyst Ratings

$2.48

+0.11 (+4.64%)

(As of 07/5/2022 03:59 PM ET)

Add

Compare

Today's Range: $2.25
▼
$2.48
50-Day Range: $2.28
▼
$5.35
52-Week Range: $2.25
▼
$11.40

Volume: 742,564 shs
Average Volume: 241,828 shs
Market Capitalization: $457.66 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $12.73

TerrAscend (OTCMKTS:TRSSF) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 9 Analyst Ratings

Consensus Analyst Price Target

$11.08
346.77% Upside

High Prediction	$17.00
Average Prediction	$11.08
Low Prediction	$7.90

Type	Current 7/5/21 to 7/5/22	1 Month Ago 6/5/21 to 6/5/22	3 Months Ago 4/6/21 to 4/6/22	1 Year Ago 7/5/20 to 7/5/21
Consensus Rating	Moderate Buy	Moderate Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	8 Buy rating(s)	6 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$11.08	$11.08	$11.08	$18.54
Predicted Upside	346.77% Upside	56.89% Upside	56.89% Upside	44.18% Upside

Get TerrAscend Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter.

TRSSF Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TRSSF Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

TerrAscend Stock vs. The Competition

Type	TerrAscend	Medical Companies	S&P 500
Consensus Rating Score	2.89	2.72	2.51
Consensus Rating	Moderate Buy	Buy	Buy
Predicted Upside	367.51% Upside	458.03% Upside	31.83% Upside
News Sentiment Rating	Neutral News	Positive News	Neutral News
MarketBeat Community Rating	Outperform Votes 67 91.78% Underperform Votes 6 8.22%	Avg. Outperform Votes 167 67.07% Avg. Underperform Votes 82 32.93%	Avg. Outperform Votes 840 69.14% Avg. Underperform Votes 375 30.86%

Historical TerrAscend Price Targets and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/13/2022	Echelon Wealth Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Semple Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold
3/17/2022	Clarus Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Atkinson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
3/17/2022	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$8.00	+61.62%
3/17/2022	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$7.65 ➝ $7.90	+59.60%
3/16/2022	Atb Cap Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Tyghe Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
11/17/2021	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	C$23.00 ➝ C$21.00
8/20/2021	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Top Pick ➝ Buy	$21.50 ➝ $13.50	+82.41%
8/20/2021	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vivien Azer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	$13.00 ➝ $9.00	+21.61%
7/7/2021	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$17.00	+53.26%
12/21/2020	Beacon Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$13.50	+28.57%

6/15/2020	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy

(Data available from 7/5/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

TerrAscend Price Target - Frequently Asked Questions

What is TerrAscend's consensus rating and price target?: According to the issued ratings of 9 analysts in the last year, the consensus rating for TerrAscend stock is Moderate Buy based on the current 1 hold rating and 8 buy ratings for TRSSF. The average twelve-month price prediction for TerrAscend is $11.08 with a high price target of $17.00 and a low price target of $7.90. Learn more on TRSSF's analyst rating history.
Do Wall Street analysts like TerrAscend more than its competitors?: Analysts like TerrAscend stock more than the stock of other Medical companies. The consensus rating for TerrAscend is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how TRSSF compares to other companies.
Do MarketBeat users like TerrAscend more than its competitors?: MarketBeat users like TerrAscend stock more than the stock of other Medical companies. 91.78% of MarketBeat users gave TerrAscend an outperform vote while medical companies recieve an average of 67.07% outperform votes by MarketBeat users.

Does TerrAscend's stock price have much upside?: According to analysts, TerrAscend's stock has a predicted upside of 56.89% based on their 12-month price targets.
What analysts cover TerrAscend?: TerrAscend has been rated by Echelon Wealth Partners in the past 90 days.

This page (OTCMKTS:TRSSF) was last updated on 7/5/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms